These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34074608)

  • 1. Comparison of risk of anticholinergic utilization for treatment of neurogenic bladder between in utero or postnatal myelomeningocele repair.
    Zaccaria L; Daugherty M; Grant C; Strine AC; Reddy PP; DeFoor WR; Minevich E; Lim FY; VanderBrink BA
    J Pediatr Urol; 2021 Aug; 17(4):525.e1-525.e7. PubMed ID: 34074608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era: hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt).
    Elbabaa SK; Gildehaus AM; Pierson MJ; Albers JA; Vlastos EJ
    Childs Nerv Syst; 2017 Jul; 33(7):1157-1168. PubMed ID: 28470384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal myelomeningocele repair: Do bladders better?
    Horst M; Mazzone L; Schraner T; Bodmer C; Möhrlen U; Meuli M; Gobet R
    Neurourol Urodyn; 2017 Aug; 36(6):1651-1658. PubMed ID: 27862250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urodynamic and imaging findings in infants with myelomeningocele may predict need for future augmentation cystoplasty.
    Corona LE; Lee T; Marchetti K; S Streur C; Ivancic V; Kraft KH; Bloom DA; Wan J; Park JM
    J Pediatr Urol; 2019 Dec; 15(6):644.e1-644.e5. PubMed ID: 31653462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In utero closure of myelomeningocele does not improve lower urinary tract function.
    Lee NG; Gomez P; Uberoi V; Kokorowski PJ; Khoshbin S; Bauer SB; Estrada CR
    J Urol; 2012 Oct; 188(4 Suppl):1567-71. PubMed ID: 22917751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial urological evaluation and management of children with neurogenic bladder due to myelomeningocele.
    Sager C; Burek C; Corbetta JP; Weller S; Ruiz J; Perea R; Lago E; Gomez Y; Durán V; López JC
    J Pediatr Urol; 2017 Jun; 13(3):271.e1-271.e5. PubMed ID: 28215830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In utero myelomeningocele repair and high-risk bladder pattern. a prospective study.
    Macedo A; Ottoni SL; Moron A; Cavalheiro S; da Cruz ML
    Int Braz J Urol; 2022; 48(4):672-678. PubMed ID: 35373958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How early is early? Effect of oxybutynin on bladder dynamics within the first year of life in patients with spina bifida.
    Lee AS; Viseshsindh W; Long CJ; Frazier JR; Moran MH; Zderic SA; Weiss DA
    J Pediatr Urol; 2020 Apr; 16(2):168.e1-168.e6. PubMed ID: 32115375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case report.
    Kato T; Mizuno K; Nishio H; Yasui T; Hayashi Y
    J Med Case Rep; 2021 Feb; 15(1):86. PubMed ID: 33602290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparative Analysis of Bladder Pattern of Patients who Underwent In Utero Versus Postnatal Myelomeningocele Repair.
    Parizi JLG; Leal da Cruz M; Andrade MC; Garrone G; Ottoni SL; Cavalheiro S; Moron A; Macedo A
    J Urol; 2020 Jan; 203(1):194-199. PubMed ID: 31479395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early postnatal bladder function in fetoscopic myelomeningocele repair patients.
    Huang GO; Belfort MA; Whitehead WE; Olutoye OO; Castillo J; Castillo H; Ostermaier KK; Koh CJ; Tu DD
    J Pediatr Rehabil Med; 2017 Dec; 10(3-4):327-333. PubMed ID: 29125525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting the success of intradetrusor onabotulinum toxin-A treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort.
    Danacioglu YO; Keser F; Ersoz C; Polat S; Avci AE; Kalkan S; Silay MS
    J Pediatr Urol; 2021 Aug; 17(4):520.e1-520.e7. PubMed ID: 33712371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urological evaluation of patients that had undergone in utero myelomeningocele closure: A prospective assessment at first presentation and early follow-up. Do their bladder benefit from it?
    Macedo A; Leal M; Rondon A; Ortiz V; Moron AF; Cavalheiro S
    Neurourol Urodyn; 2015 Jun; 34(5):461-4. PubMed ID: 24729268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero myelomeningocele repair and incidence of lower urinary tract surgery. Results of a prospective study.
    Macedo A; Ottoni SL; Garrone G; Moron A; Cavalheiro S; Leal da Cruz M
    J Pediatr Urol; 2021 Dec; 17(6):769-774. PubMed ID: 34452829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of Bacteriuria in Myelomeningocele Patients at Time of Urodynamic Testing.
    Preece J; Haynes A; Gupta S; Becknell B; Ching C
    Top Spinal Cord Inj Rehabil; 2019; 25(3):241-247. PubMed ID: 31548791
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum injection is useless on fibrotic neuropathic bladders.
    Tiryaki S; Yagmur I; Parlar Y; Ozel K; Akyildiz C; Avanoglu A; Ulman I
    J Pediatr Urol; 2015 Feb; 11(1):27.e1-4. PubMed ID: 25448589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urodynamic characteristics of neurogenic bladder in newborns with myelomeningocele and refinement of the definition of bladder hostility: Findings from the UMPIRE multi-center study.
    Tanaka ST; Yerkes EB; Routh JC; Tu DD; Austin JC; Wiener JS; Vasquez E; Joseph DB; Ahn JJ; Wallis MC; Williams T; Rose C; Baum MA; Cheng EY
    J Pediatr Urol; 2021 Oct; 17(5):726-732. PubMed ID: 34011486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamic Findings and Renal Function in Children with Neurogenic Bladder after Myelomeningocele.
    Korzeniecka-Kozerska A; Porowski T; Bagińska J; Wasilewska A
    Urol Int; 2015; 95(2):146-52. PubMed ID: 26067248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of long-term medical treatment combined with clean intermittent catheterization in children with neurogenic detrusor overactivity.
    Lehnert T; Weisser M; Till H; Rolle U
    Int Urol Nephrol; 2012 Apr; 44(2):335-41. PubMed ID: 21779920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of non-surgical management of detrusor leak point pressures above 40 cm water in adults with congenital neurogenic bladder.
    Lane GI; Gor RA; Katorski J; Elliott SP
    Neurourol Urodyn; 2018 Aug; 37(6):1943-1949. PubMed ID: 29488655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.